Anna Barattucci

Prof. Dr. Anna Barattucci

Università degli Studi di Messina, Messina, Italy
orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 1997 in Tetrahedron: Asymmetry
Verified
Journal Article
Closed access
MAMaria C. Aversa
Maria C. Aversa
Anna BarattucciAnna Barattucci
Anna Barattucci
Paola BonaccorsiPaola Bonaccorsi
Paola Bonaccorsi
PGPlacido Giannetto
Placido Giannetto

1 June 1997 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
MAMaria C. Aversa
Maria C. Aversa
Anna BarattucciAnna Barattucci
Anna Barattucci
Paola BonaccorsiPaola Bonaccorsi
Paola Bonaccorsi
PGPlacido Giannetto
Placido Giannetto
DJDavid Neville Jones
David Neville Jones

1 November 2014 in Dyes and Pigments
Verified
Journal Article
Closed access
TPTeresa Papalia
Teresa Papalia
GSGabriel Siracusano
Gabriel Siracusano
ICIvana Colao
Ivana Colao
Anna BarattucciAnna Barattucci
Anna Barattucci
MAMaria Chiara Aversa
Maria Chiara Aversa
Paola BonaccorsiPaola Bonaccorsi
Paola Bonaccorsi

7 September 2012 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
Paola BonaccorsiPaola Bonaccorsi
Paola Bonaccorsi
MAMaria Chiara Aversa
Maria Chiara Aversa
Anna BarattucciAnna Barattucci
Anna Barattucci
TPTeresa Papalia
Teresa Papalia
Fausto PuntorieroFausto Puntoriero
Fausto Puntoriero
SCSebastiano Campagna
Sebastiano Campagna
An enantiopure α-D-glucopyranoside derivative has been used as a platform to prepare artificial antenna systems based on bodipy subunits. Efficient and ultrafast energy transfer (in the fs and ps time regimes) takes place in the multibodipy systems.

1 August 2008 in Tetrahedron
Verified
Journal Article
Closed access
MAMaria Chiara Aversa
Maria Chiara Aversa
Anna BarattucciAnna Barattucci
Anna Barattucci
Paola BonaccorsiPaola Bonaccorsi
Paola Bonaccorsi

26 October 2019 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Paola BonaccorsiPaola Bonaccorsi
Paola Bonaccorsi
MLManuela Labbozzetta
Manuela Labbozzetta
Anna BarattucciAnna Barattucci
Anna Barattucci
TSTania Maria Grazia Salerno
Tania Maria Grazia Salerno
Paola PomaPaola Poma
Paola Poma
Monica NotarbartoloMonica Notarbartolo
Monica Notarbartolo
We analyzed antitumor effects of a series of curcumin analogues. Some of them were obtained by reaction of substitution involving the two phenolic OH groups of curcumin while the analogues with a substituent at C-4 was prepared following an original procedure that regards the condensation of benzenesulfenic acid onto the nucleophilic central carbon of the curcumin skeleton. We analyzed cytotoxic effects of such derivatives on two TNBC (triple negative breast cancer) cell lines, SUM 149 and MDA-MB-231, but only three of them showed an IC50 in a lower micromolar range with respect to curcumin. We also focused on these three derivatives that in both cell lines exhibited a higher or at least equivalent pro-apoptotic effect than curcumin. The analysis of molecular mechanisms of action of the curcumin derivatives under study has highlighted that they decreased NF-κB transcriptional factor activity, and consequently the expression of some NF-κB targets. Our data confirmed once again that curcumin may represent a very good lead compound to design analogues with higher antitumor capacities and able to overcome drug resistance with respect to conventional ones, even in tumors difficult to treat as TNBC.